114 related articles for article (PubMed ID: 37937329)
1. Neuropeptide Y is elevated in heart failure and is an independent predictor of outcomes.
McDowell K; Adamson C; Jackson C; Campbell R; Welsh P; Petrie MC; McMurray JJV; Jhund PS; Herring N
Eur J Heart Fail; 2024 Jan; 26(1):107-116. PubMed ID: 37937329
[TBL] [Abstract][Full Text] [Related]
2. Coronary Sinus Neuropeptide Y Levels and Adverse Outcomes in Patients With Stable Chronic Heart Failure.
Ajijola OA; Chatterjee NA; Gonzales MJ; Gornbein J; Liu K; Li D; Paterson DJ; Shivkumar K; Singh JP; Herring N
JAMA Cardiol; 2020 Mar; 5(3):318-325. PubMed ID: 31876927
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide-Y Levels in ST-Segment-Elevation Myocardial Infarction: Relationship With Coronary Microvascular Function, Heart Failure, and Mortality.
Gibbs T; Tapoulal N; Shanmuganathan M; Burrage MK; Borlotti A; Banning AP; Choudhury RP; Neubauer S; Kharbanda RK; Ferreira VM; Channon KM; Herring N;
J Am Heart Assoc; 2022 Jul; 11(13):e024850. PubMed ID: 35766271
[TBL] [Abstract][Full Text] [Related]
4. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
[TBL] [Abstract][Full Text] [Related]
5. Variability in estimated glomerular filtration rate and patients' outcomes in a real-world heart failure population.
Oka T; Hamano T; Ohtani T; Tanaka A; Doi Y; Yamaguchi S; Senda M; Sakaguchi Y; Matsui I; Nakamoto K; Sera F; Hikoso S; Nishino M; Sakata Y; Isaka Y
ESC Heart Fail; 2021 Dec; 8(6):4976-4987. PubMed ID: 34554643
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of brain natriuretic peptide level at implant in predicting mortality in patients with advanced but stable heart failure receiving cardiac resynchronization therapy.
El-Saed A; Voigt A; Shalaby A
Clin Cardiol; 2009 Nov; 32(11):E33-8. PubMed ID: 19816874
[TBL] [Abstract][Full Text] [Related]
7. Combination of ST2 and B-type natriuretic peptide in diabetic patients with acute heart failure: relation with ventricular stiffness and outcome.
Ruocco G; Evangelista I; Franci B; Lucani B; Martini S; Nuti R; Palazzuoli A
J Cardiovasc Med (Hagerstown); 2019 Feb; 20(2):81-90. PubMed ID: 30540645
[TBL] [Abstract][Full Text] [Related]
8. Clinical Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Disease: Insights From PARADIGM-HF.
Ehteshami-Afshar S; Mooney L; Dewan P; Desai AS; Lang NN; Lefkowitz MP; Petrie MC; Rizkala AR; Rouleau JL; Solomon SD; Swedberg K; Shi VC; Zile MR; Packer M; McMurray JJV; Jhund PS; Hawkins NM
J Am Heart Assoc; 2021 Feb; 10(4):e019238. PubMed ID: 33522249
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic value of N-terminal B-type natriuretic peptide on all-cause mortality in heart failure patients with preserved ejection fraction].
Cao J; Jin XJ; Zhou J; Chen ZY; Xu DL; Yang XC; Dong W; Li LW; Luo J; Chen L; Fu M; Zhou JM; Ge JB
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):875-881. PubMed ID: 31744276
[No Abstract] [Full Text] [Related]
10. The prognostic value of brain natriuretic peptide in patients with heart failure and left ventricular ejection fraction higher than 60%: a sub-analysis of the J-MELODIC study.
Kitada S; Kikuchi S; Tsujino T; Masuyama T; Ohte N;
ESC Heart Fail; 2018 Feb; 5(1):36-45. PubMed ID: 28941144
[TBL] [Abstract][Full Text] [Related]
11. B-type natriuretic peptide levels in obese patients with advanced heart failure.
Horwich TB; Hamilton MA; Fonarow GC
J Am Coll Cardiol; 2006 Jan; 47(1):85-90. PubMed ID: 16386669
[TBL] [Abstract][Full Text] [Related]
12. Prior Pacemaker Implantation and Clinical Outcomes in Patients With Heart Failure and Preserved Ejection Fraction.
Shen L; Jhund PS; Docherty KF; Petrie MC; Anand IS; Carson PE; Desai AS; Granger CB; Komajda M; McKelvie RS; Pfeffer MA; Solomon SD; Swedberg K; Zile MR; McMurray JJV
JACC Heart Fail; 2019 May; 7(5):418-427. PubMed ID: 30981744
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide Y, noradrenaline and invasive haemodynamic data in mild to moderate chronic congestive heart failure.
Ullman B; Jensen-Urstad M; Hulting J; Lundberg JM
Clin Physiol; 1993 Jul; 13(4):409-18. PubMed ID: 8370239
[TBL] [Abstract][Full Text] [Related]
14. [The clinical value of B-type natriuretic peptide in the diagnosis of left heart failure].
Zhao XY; Yang YJ; Zhang J; Dang AM; Ni XH; Huang J; Kang S; Ma WH; Zhao DY
Zhonghua Yi Xue Za Zhi; 2006 May; 86(17):1165-9. PubMed ID: 16796855
[TBL] [Abstract][Full Text] [Related]
15. BNP and obesity in acute decompensated heart failure with preserved vs. reduced ejection fraction: The Atherosclerosis Risk in Communities Surveillance Study.
Khalid U; Wruck LM; Quibrera PM; Bozkurt B; Nambi V; Virani SS; Jneid H; Agarwal S; Chang PP; Loehr L; Basra SS; Rosamond W; Ballantyne CM; Deswal A
Int J Cardiol; 2017 Apr; 233():61-66. PubMed ID: 28185703
[TBL] [Abstract][Full Text] [Related]
16. New echocardiographic predictors of clinical outcome in patients presenting with heart failure and a preserved left ventricular ejection fraction: a subanalysis of the Ka (Karolinska) Ren (Rennes) Study.
Donal E; Lund LH; Oger E; Hage C; Persson H; Reynaud A; Ennezat PV; Bauer F; Drouet E; Linde C; Daubert C;
Eur J Heart Fail; 2015 Jul; 17(7):680-8. PubMed ID: 26033771
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation.
Kristensen SL; Jhund PS; Mogensen UM; Rørth R; Abraham WT; Desai A; Dickstein K; Rouleau JL; Zile MR; Swedberg K; Packer M; Solomon SD; Køber L; McMurray JJV;
Circ Heart Fail; 2017 Oct; 10(10):. PubMed ID: 29018174
[TBL] [Abstract][Full Text] [Related]
19. Worsening Renal Function during Management for Chronic Heart Failure with Reduced Ejection Fraction: Results From the Pro-BNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study.
Ibrahim NE; Gaggin HK; Rabideau DJ; Gandhi PU; Mallick A; Januzzi JL
J Card Fail; 2017 Feb; 23(2):121-130. PubMed ID: 27469482
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes according to QRS duration and morphology in the irbesartan in patients with heart failure and preserved systolic function (I-PRESERVE) trial.
Cannon JA; Shen L; Jhund PS; Anand IS; Komajda M; McKelvie RS; Zile MR; Carson PE; McMurray JJ
Eur J Heart Fail; 2016 Aug; 18(8):1021-31. PubMed ID: 27194023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
